Immunogenicity and protective efficacy on non-adjuvanted CD40-targeting SARS-CoV-2 vaccines in non-human primates.
Saved in:
| Title: | Immunogenicity and protective efficacy on non-adjuvanted CD40-targeting SARS-CoV-2 vaccines in non-human primates. |
|---|---|
| Authors: | Marlin R; Université Paris-Saclay, Inserm, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184); Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Centlivre M; Vaccine Research Institute, Créteil, France; Inserm U955, Equipe 16, Institut Mondor de Recherche Biomédicale, Université Paris-Est Créteil, Créteil, France., Bossevot L; Université Paris-Saclay, Inserm, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184); Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Gallouët AS; Université Paris-Saclay, Inserm, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184); Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Alexandre M; Vaccine Research Institute, Créteil, France; Université de Bordeaux, Inserm U1219 Bordeaux Population Health Research Centre, Inria SISTM, 33000, Bordeaux, France., Planas D; Vaccine Research Institute, Créteil, France; Virus and Immunity Unit, Institut Pasteur, Université Paris Cité, Paris, France., Cavarelli M; Université Paris-Saclay, Inserm, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184); Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Staropoli I; Virus and Immunity Unit, Institut Pasteur, Université Paris Cité, Paris, France., Gros W; Université Paris-Saclay, Inserm, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184); Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Surenaud M; Vaccine Research Institute, Créteil, France; Inserm U955, Equipe 16, Institut Mondor de Recherche Biomédicale, Université Paris-Est Créteil, Créteil, France., Fenwick C; Service of Immunology and Allergy, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Cardinaud S; Vaccine Research Institute, Créteil, France; Inserm U955, Equipe 16, Institut Mondor de Recherche Biomédicale, Université Paris-Est Créteil, Créteil, France., Galhaut M; Université Paris-Saclay, Inserm, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184); Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Zurawski S; Vaccine Research Institute, Créteil, France; Baylor Scott and White Research Institute and Inserm U955, Dallas, TX, United States of America., Magneron V; Université Paris-Saclay, Inserm, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184); Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Pintore L; Université Paris-Saclay, Inserm, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184); Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Hérate C; Université Paris-Saclay, Inserm, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184); Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Rameix Welti MA; National Reference Center for Respiratory Viruses, Molecular Mechanisms of Multiplication of Pneumoviruses Unit, Institut Pasteur, Université Paris Cité, Paris, France; Molecular Mechanisms of Multiplication of Pneumoviruses, Université Paris-Saclay, Université de Versailles St. Quentin, UMR 1173 (2I), INSERM, Assistance Publique des Hôpitaux de Paris, Paris, France., Mazet P; Université Paris-Saclay, Inserm, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184); Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Contreras V; Université Paris-Saclay, Inserm, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184); Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Relouzat F; Université Paris-Saclay, Inserm, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184); Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Dereuddre-Bosquet N; Université Paris-Saclay, Inserm, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184); Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Pantaleo G; Vaccine Research Institute, Créteil, France; Inserm U955, Equipe 16, Institut Mondor de Recherche Biomédicale, Université Paris-Est Créteil, Créteil, France; Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland., Thiébaut R; Vaccine Research Institute, Créteil, France; Université de Bordeaux, Inserm U1219 Bordeaux Population Health Research Centre, Inria SISTM, 33000, Bordeaux, France; CHU Bordeaux, Department of Medical information, Bordeaux, France., Prague M; Vaccine Research Institute, Créteil, France; Université de Bordeaux, Inserm U1219 Bordeaux Population Health Research Centre, Inria SISTM, 33000, Bordeaux, France., Schwartz O; Vaccine Research Institute, Créteil, France; Virus and Immunity Unit, Institut Pasteur, Université Paris Cité, Paris, France., Zurawski G; Vaccine Research Institute, Créteil, France; Baylor Scott and White Research Institute and Inserm U955, Dallas, TX, United States of America., Godot V; Vaccine Research Institute, Créteil, France; Inserm U955, Equipe 16, Institut Mondor de Recherche Biomédicale, Université Paris-Est Créteil, Créteil, France., Le Grand R; Université Paris-Saclay, Inserm, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184); Fontenay-aux-Roses & Le Kremlin-Bicêtre, France. Electronic address: roger.le-grand@cea.fr., Lévy Y; Vaccine Research Institute, Créteil, France; Inserm U955, Equipe 16, Institut Mondor de Recherche Biomédicale, Université Paris-Est Créteil, Créteil, France; AP-HP, Hôpital Henri-Mondor Albert-Chenevier, Service d'Immunologie Clinique et Maladies Infectieuses, Créteil, France. Electronic address: yves.levy@inserm.fr. |
| Source: | EBioMedicine [EBioMedicine] 2026 Jul; Vol. 129, pp. 106361. Date of Electronic Publication: 2026 Jul 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
